Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Use of GnRH antagonists in the treatment of early ovarian hyperstimulation syndrome
2009-011108-46Phase 2Completed
- Sponsor
- Instituto Universitario IVI
- Start
- Dec 2009
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2 trial of ganirelix in ovarian hyperstimulation syndrome (OHSS) (2 arms), sponsored by Instituto Universitario IVI. Started Dec 2009; status: completed.
02
Drugs
ganirelix
03
Conditions
ovarian hyperstimulation syndrome (OHSS)
Beyond the preview
Go deeper on 2009-011108-46.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011108-46.